JS Capital Management’s Insmed INSM Stock Holding History

JS Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,200	Closed	-$521K	–	167
2020 Q3	$521K	Buy	+16,200	New	+$466K	0.03%	66

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JS Capital Management's INSM Position: Q4 2020 in Review

JS Capital Management sold out of Insmed (INSM) in Q4 2020, closing a stake of 16,200 shares — an estimated $521K sold.

JS Capital Management first reported a position in INSM in Q3 2020 and held it in 1 quarter. The position peaked at $521K in Q3 2020. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

JS Capital Management reported no remaining Insmed position as of Q4 2020 after selling out during the quarter.
JS Capital Management sold 16,200 Insmed shares in Q4 2020, an estimated $521K.
JS Capital Management first reported a position in Insmed in Q3 2020 and held it in 1 quarter.
JS Capital Management's Insmed position peaked at $521K in Q3 2020.
206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on JS Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.